DxS to Increase Research Capabilities With the Expansion of the Product Development Team
DxS has announced the expansion of its Product Development Team in response to a marked rise in demand for its cancer diagnostics kits in 2008. The Company has significantly increased its number of Research and Development staff in the final quarter of the year from four at the start of the year to eight, and plans to recruit a further five more Product Development Scientists in the next month.
David Whitcombe, Chief Scientific Officer at DxS said, “The quality and range of our products is centrally based upon the innovation and experience of our Development Team. Our scientists are dedicated to ensuring that we remain the market leaders in our field and lead the way in developing novel assays for the future”.
Dr. Simon Flint joined DxS from the University of Sussex and brought with him a background in post-doctoral academic research in molecular biology and biochemical techniques specialising in translation initiation and antibiotic biosynthesis.
Dr. Sarah Gray started in October with a PhD in Molecular Biology from the Royal College of Surgeons in Ireland. Sarah has a wealth of research experience and specialises in DNA extraction and PCR techniques.
In November Ian Riley and Dr. Elloise Garside joined the Company. Ian has eleven years of experience at AstraZeneca, focusing on DNA sequencing and real-time PCR methods within the Clinical Genotyping Group. Elloise joined from the Manchester Interdisciplinary Biocentre at the University of Manchester where she was a Post-Doctoral Research Associate. Prior to that Elloise worked as a Medical Writer at Pyxis Medical Communications.
Rachael Carters worked as a member of the DxS Service Team during her Industrial Placement year as part of a BSc in Biology at the University of Manchester. Responsible for the development of new assays and project work comparing DxS’ Scorpions® real-time PCR technology with other molecular beacons, Rachael’s aptitude for the role was rewarded when she was offered a permanent position in Product Development after she graduated in July 2008.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
